1. Home
  2. ANEB vs SCNX Comparison

ANEB vs SCNX Comparison

Compare ANEB & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANEB
  • SCNX
  • Stock Information
  • Founded
  • ANEB 2020
  • SCNX 2010
  • Country
  • ANEB United States
  • SCNX United States
  • Employees
  • ANEB N/A
  • SCNX N/A
  • Industry
  • ANEB Biotechnology: Pharmaceutical Preparations
  • SCNX Other Pharmaceuticals
  • Sector
  • ANEB Health Care
  • SCNX Health Care
  • Exchange
  • ANEB Nasdaq
  • SCNX Nasdaq
  • Market Cap
  • ANEB 98.6M
  • SCNX 21.2M
  • IPO Year
  • ANEB 2021
  • SCNX 2020
  • Fundamental
  • Price
  • ANEB $2.44
  • SCNX N/A
  • Analyst Decision
  • ANEB Buy
  • SCNX
  • Analyst Count
  • ANEB 2
  • SCNX 0
  • Target Price
  • ANEB $8.00
  • SCNX N/A
  • AVG Volume (30 Days)
  • ANEB 46.1K
  • SCNX 439.4K
  • Earning Date
  • ANEB 11-12-2025
  • SCNX 11-05-2025
  • Dividend Yield
  • ANEB N/A
  • SCNX N/A
  • EPS Growth
  • ANEB N/A
  • SCNX N/A
  • EPS
  • ANEB N/A
  • SCNX N/A
  • Revenue
  • ANEB N/A
  • SCNX $128,202.00
  • Revenue This Year
  • ANEB N/A
  • SCNX N/A
  • Revenue Next Year
  • ANEB N/A
  • SCNX N/A
  • P/E Ratio
  • ANEB N/A
  • SCNX N/A
  • Revenue Growth
  • ANEB N/A
  • SCNX N/A
  • 52 Week Low
  • ANEB $0.80
  • SCNX $0.68
  • 52 Week High
  • ANEB $3.42
  • SCNX $9.55
  • Technical
  • Relative Strength Index (RSI)
  • ANEB 56.77
  • SCNX 29.29
  • Support Level
  • ANEB $2.26
  • SCNX $0.67
  • Resistance Level
  • ANEB $2.39
  • SCNX $0.89
  • Average True Range (ATR)
  • ANEB 0.11
  • SCNX 0.05
  • MACD
  • ANEB 0.00
  • SCNX 0.01
  • Stochastic Oscillator
  • ANEB 76.46
  • SCNX 17.66

About ANEB Anebulo Pharmaceuticals Inc.

Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies.

About SCNX Scienture Holdings Inc. Common Stock

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

Share on Social Networks: